Vikram Kamats [VIDLI] vs India Glycols [INDIAGLYCO] Detailed Stock Comparison

Vikram Kamats
BSE
Loading...

India Glycols
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vikram Kamats wins in 7 metrics, India Glycols wins in 12 metrics, with 0 ties. India Glycols appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Vikram Kamats | India Glycols | Better |
---|---|---|---|
P/E Ratio (TTM) | 93.75 | 20.49 | India Glycols |
Price-to-Book Ratio | 2.82 | 2.21 | India Glycols |
Debt-to-Equity Ratio | 1.40 | 83.85 | Vikram Kamats |
PEG Ratio | 50.61 | -0.52 | India Glycols |
EV/EBITDA | 26.02 | 12.76 | India Glycols |
Profit Margin (TTM) | 55.43% | 6.35% | Vikram Kamats |
Operating Margin (TTM) | 12.38% | 11.07% | Vikram Kamats |
EBITDA Margin (TTM) | 12.38% | 11.07% | Vikram Kamats |
Return on Equity | 7.07% | 10.24% | India Glycols |
Return on Assets (TTM) | 2.60% | 3.74% | India Glycols |
Free Cash Flow (TTM) | $-192.24M | $-3.98B | Vikram Kamats |
Dividend Yield | 0.48% | 0.42% | Vikram Kamats |
1-Year Return | -20.15% | 28.23% | India Glycols |
Price-to-Sales Ratio (TTM) | 4.09 | 1.30 | India Glycols |
Enterprise Value | $1.39B | $68.10B | India Glycols |
EV/Revenue Ratio | 5.06 | 1.77 | India Glycols |
Gross Profit Margin (TTM) | 52.11% | 34.89% | Vikram Kamats |
Revenue per Share (TTM) | $25 | $620 | India Glycols |
Earnings per Share (Diluted) | $1.43 | $39.37 | India Glycols |
Beta (Stock Volatility) | N/A | 0.26 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vikram Kamats vs India Glycols Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Vikram Kamats | 3.23% | 1.70% | -7.55% | -12.26% | -16.12% | -20.73% |
India Glycols | 10.73% | -8.74% | -20.73% | -5.85% | 40.12% | 24.78% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Vikram Kamats | -20.15% | 84.91% | 306.80% | 306.80% | 306.80% | 306.80% |
India Glycols | 28.23% | 92.63% | 454.58% | 1,566.25% | 1,217.22% | 827.68% |
Performance & Financial Health Analysis: Vikram Kamats vs India Glycols
Metric | VIDLI | INDIAGLYCO |
---|---|---|
Market Information | ||
Market Cap | ₹1.12B | ₹49.96B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 3,799 | 260,384 |
90 Day Avg. Volume | 2,694 | 255,984 |
Last Close | ₹62.99 | ₹893.40 |
52 Week Range | ₹53.80 - ₹89.60 | ₹503.52 - ₹1,069.00 |
% from 52W High | -29.70% | -16.43% |
All-Time High | ₹187.00 (Jan 09, 2017) | ₹2,138.00 (Jun 30, 2025) |
% from All-Time High | -66.32% | -58.21% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.23% | 0.07% |
Quarterly Earnings Growth | 0.30% | 0.21% |
Financial Health | ||
Profit Margin (TTM) | 0.55% | 0.06% |
Operating Margin (TTM) | 0.12% | 0.11% |
Return on Equity (TTM) | 0.07% | 0.10% |
Debt to Equity (MRQ) | 1.40 | 83.85 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹22.22 | ₹364.35 |
Cash per Share (MRQ) | N/A | ₹12.51 |
Operating Cash Flow (TTM) | ₹-132,509,000 | ₹5.04B |
Levered Free Cash Flow (TTM) | ₹15.60M | ₹2.31B |
Dividends | ||
Last 12-Month Dividend Yield | 0.48% | 0.42% |
Last 12-Month Dividend | ₹0.30 | ₹8.00 |
Valuation & Enterprise Metrics Analysis: Vikram Kamats vs India Glycols
Metric | VIDLI | INDIAGLYCO |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 93.75 | 20.49 |
Forward P/E | N/A | N/A |
PEG Ratio | 50.61 | -0.52 |
Price to Sales (TTM) | 4.09 | 1.30 |
Price to Book (MRQ) | 2.82 | 2.21 |
Market Capitalization | ||
Market Capitalization | ₹1.12B | ₹49.96B |
Enterprise Value | ₹1.39B | ₹68.10B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.06 | 1.77 |
Enterprise to EBITDA | 26.02 | 12.76 |
Risk & Other Metrics | ||
Beta | N/A | 0.26 |
Book Value per Share (MRQ) | ₹22.22 | ₹364.35 |
Financial Statements Comparison: Vikram Kamats vs India Glycols
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | VIDLI | INDIAGLYCO |
---|---|---|
Revenue/Sales | ₹103.39M | ₹10.40B |
Cost of Goods Sold | ₹49.51M | ₹6.77B |
Gross Profit | ₹53.88M | ₹3.63B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹6.28M | ₹1.15B |
EBITDA | ₹24.31M | ₹1.70B |
Pre-Tax Income | ₹3.89M | ₹905.30M |
Income Tax | ₹1.31M | ₹172.80M |
Net Income (Profit) | ₹2.58M | ₹732.50M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | VIDLI | INDIAGLYCO |
---|---|---|
Cash & Equivalents | ₹20.76M | ₹68.40M |
Total Current Assets | ₹129.97M | ₹18.16B |
Total Current Liabilities | ₹157.07M | ₹23.21B |
Long-Term Debt | ₹328.50M | ₹11.07B |
Total Shareholders Equity | ₹286.71M | ₹22.56B |
Retained Earnings | N/A | N/A |
Property, Plant & Equipment | ₹317.20M | ₹38.26B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | VIDLI | INDIAGLYCO |
---|---|---|
Operating Cash Flow | N/A | ₹1.02B |
Capital Expenditures | N/A | ₹-2.12B |
Free Cash Flow | N/A | ₹-426.90M |
Debt Repayment | N/A | ₹-580.00M |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | VIDLI | INDIAGLYCO |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 3,799 | 260,384 |
Average Daily Volume (90 Day) | 2,694 | 255,984 |
Shares Outstanding | 11.86M | 30.96M |
Float Shares | N/A | 20.53M |
% Held by Insiders | N/A | 0.64% |
% Held by Institutions | N/A | 0.01% |
Dividend Analysis & Yield Comparison: Vikram Kamats vs India Glycols
Metric | VIDLI | INDIAGLYCO |
---|---|---|
Last 12-Month Dividend | ₹0.30 | ₹8.00 |
Last 12-Month Dividend Yield | 0.48% | 0.42% |
3-Year Avg Annual Dividend | ₹0.27 | ₹7.67 |
3-Year Avg Dividend Yield | 0.53% | 0.83% |
3-Year Total Dividends | ₹0.80 | ₹23.00 |
Ex-Dividend Date | Sep 20, 2024 | Aug 21, 2024 |